Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
31.78
+2.07 (6.97%)
At close: Oct 3, 2025, 4:00 PM EDT
31.77
-0.01 (-0.03%)
After-hours: Oct 3, 2025, 7:51 PM EDT

Caris Life Sciences Stock Forecast

Stock Price Forecast

The 6 analysts that cover Caris Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $35.5, which forecasts a 11.71% increase in the stock price over the next year. The lowest target is $31 and the highest is $42.

Price Target: $35.5 (+11.71%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$31$35.5$36$42
Change-2.45%+11.71%+13.28%+32.16%
* Price targets were last updated on Aug 13, 2025.

Analyst Ratings

The average analyst rating for Caris Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy003333
Buy003333
Hold330000
Sell000000
Strong Sell000000
Total336666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Strong Buy
Maintains
$32$36
Strong BuyMaintains$32$36+13.28%Aug 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$33$40
BuyMaintains$33$40+25.87%Aug 13, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$34$42
Strong BuyMaintains$34$42+32.16%Aug 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$33
BuyInitiates$33+3.84%Jul 15, 2025
TD Cowen
TD Cowen
Strong Buy
Initiates
$32
Strong BuyInitiates$32+0.69%Jul 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
678.81M
from 412.26M
Increased by 64.66%
Revenue Next Year
989.77M
from 678.81M
Increased by 45.81%
EPS This Year
-2.60
from -10.66
EPS Next Year
0.28
from -2.60
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
258.49M306.13M412.26M678.81M989.77M1.23B1.44B
Revenue Growth
-18.43%34.67%64.66%45.81%24.07%17.59%
EPS
-11.98-13.24-10.66-2.600.281.101.81
EPS Growth
-----300.61%64.34%
Forward PE
----115.4728.8217.54
No. Analysts
---9986
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272028
High718.5M1.1B
Avg678.8M989.8M
Low594.7M936.3M

Revenue Growth

Revenue Growth2025202620272028
High
74.3%
55.7%
Avg
64.7%
45.8%
Low
44.2%
37.9%

EPS Forecast

EPS2025202620272028
High-0.890.51
Avg-2.600.28
Low-8.68-0.05

EPS Growth

EPS Growth2025202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.